 | • レポートコード：QYR9ST07864 • 出版社/出版日：QYResearch / 2019年9月5日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、ルキソリチニブの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、5mg錠剤、10mg錠剤、15mg錠剤、20mg錠剤に、用途別には、中等度骨髄線維症、高リスク骨髄線維症、真性多血症、その他にセグメント区分し、ルキソリチニブの世界市場を分析しました。 ・エグゼクティブ・サマリー ・ルキソリチニブの世界市場概要 ・ルキソリチニブの製造コスト構成分析 ・ルキソリチニブの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・ルキソリチニブの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・ルキソリチニブのセグメント分析（種類別） （5mg錠剤、10mg錠剤、15mg錠剤、20mg錠剤） ・ルキソリチニブのセグメント分析（用途別） （中等度骨髄線維症、高リスク骨髄線維症、真性多血症、その他） ・ルキソリチニブの主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Novartis、Shandong Chuangxin Pharmaceutical Research and Development、Orifarm AS、Incyte Corporation） ・ルキソリチニブの市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Ruxolitinib market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Ruxolitinib volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ruxolitinib market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Ruxolitinib in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Ruxolitinib manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Novartis
Shandong Chuangxin Pharmaceutical Research and Development
Orifarm AS
Incyte Corporation
…
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
5mg Tablets
10mg Tablets
15mg Tablets
20mg Tablets
Segment by Application
Moderate Myelofibrosis
High Risk Myelofibrosis
Polycythemia Vera
Other
Table of Contents
Executive Summary
1 Industry Overview of Ruxolitinib
1.1 Definition of Ruxolitinib
1.2 Ruxolitinib Segment by Type
1.2.1 Global Ruxolitinib Production Growth Rate Comparison by Types (2014-2025)
1.2.2 5mg Tablets
1.2.3 10mg Tablets
1.2.4 15mg Tablets
1.2.5 20mg Tablets
1.3 Ruxolitinib Segment by Applications
1.3.1 Global Ruxolitinib Consumption Comparison by Applications (2014-2025)
1.3.2 Moderate Myelofibrosis
1.3.3 High Risk Myelofibrosis
1.3.4 Polycythemia Vera
1.3.5 Other
1.4 Global Ruxolitinib Overall Market
1.4.1 Global Ruxolitinib Revenue (2014-2025)
1.4.2 Global Ruxolitinib Production (2014-2025)
1.4.3 North America Ruxolitinib Status and Prospect (2014-2025)
1.4.4 Europe Ruxolitinib Status and Prospect (2014-2025)
1.4.5 China Ruxolitinib Status and Prospect (2014-2025)
1.4.6 Japan Ruxolitinib Status and Prospect (2014-2025)
1.4.7 Southeast Asia Ruxolitinib Status and Prospect (2014-2025)
1.4.8 India Ruxolitinib Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Ruxolitinib
2.3 Manufacturing Process Analysis of Ruxolitinib
2.4 Industry Chain Structure of Ruxolitinib
3 Development and Manufacturing Plants Analysis of Ruxolitinib
3.1 Capacity and Commercial Production Date
3.2 Global Ruxolitinib Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Ruxolitinib
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Ruxolitinib Production and Capacity Analysis
4.2 Ruxolitinib Revenue Analysis
4.3 Ruxolitinib Price Analysis
4.4 Market Concentration Degree
5 Ruxolitinib Regional Market Analysis
5.1 Ruxolitinib Production by Regions
5.1.1 Global Ruxolitinib Production by Regions
5.1.2 Global Ruxolitinib Revenue by Regions
5.2 Ruxolitinib Consumption by Regions
5.3 North America Ruxolitinib Market Analysis
5.3.1 North America Ruxolitinib Production
5.3.2 North America Ruxolitinib Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Ruxolitinib Import and Export
5.4 Europe Ruxolitinib Market Analysis
5.4.1 Europe Ruxolitinib Production
5.4.2 Europe Ruxolitinib Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Ruxolitinib Import and Export
5.5 China Ruxolitinib Market Analysis
5.5.1 China Ruxolitinib Production
5.5.2 China Ruxolitinib Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Ruxolitinib Import and Export
5.6 Japan Ruxolitinib Market Analysis
5.6.1 Japan Ruxolitinib Production
5.6.2 Japan Ruxolitinib Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Ruxolitinib Import and Export
5.7 Southeast Asia Ruxolitinib Market Analysis
5.7.1 Southeast Asia Ruxolitinib Production
5.7.2 Southeast Asia Ruxolitinib Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Ruxolitinib Import and Export
5.8 India Ruxolitinib Market Analysis
5.8.1 India Ruxolitinib Production
5.8.2 India Ruxolitinib Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Ruxolitinib Import and Export
6 Ruxolitinib Segment Market Analysis (by Type)
6.1 Global Ruxolitinib Production by Type
6.2 Global Ruxolitinib Revenue by Type
6.3 Ruxolitinib Price by Type
7 Ruxolitinib Segment Market Analysis (by Application)
7.1 Global Ruxolitinib Consumption by Application
7.2 Global Ruxolitinib Consumption Market Share by Application (2014-2019)
8 Ruxolitinib Major Manufacturers Analysis
8.1 Novartis
8.1.1 Novartis Ruxolitinib Production Sites and Area Served
8.1.2 Novartis Product Introduction, Application and Specification
8.1.3 Novartis Ruxolitinib Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Shandong Chuangxin Pharmaceutical Research and Development
8.2.1 Shandong Chuangxin Pharmaceutical Research and Development Ruxolitinib Production Sites and Area Served
8.2.2 Shandong Chuangxin Pharmaceutical Research and Development Product Introduction, Application and Specification
8.2.3 Shandong Chuangxin Pharmaceutical Research and Development Ruxolitinib Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Orifarm AS
8.3.1 Orifarm AS Ruxolitinib Production Sites and Area Served
8.3.2 Orifarm AS Product Introduction, Application and Specification
8.3.3 Orifarm AS Ruxolitinib Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Incyte Corporation
8.4.1 Incyte Corporation Ruxolitinib Production Sites and Area Served
8.4.2 Incyte Corporation Product Introduction, Application and Specification
8.4.3 Incyte Corporation Ruxolitinib Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
9 Development Trend of Analysis of Ruxolitinib Market
9.1 Global Ruxolitinib Market Trend Analysis
9.1.1 Global Ruxolitinib Market Size (Volume and Value) Forecast 2019-2025
9.2 Ruxolitinib Regional Market Trend
9.2.1 North America Ruxolitinib Forecast 2019-2025
9.2.2 Europe Ruxolitinib Forecast 2019-2025
9.2.3 China Ruxolitinib Forecast 2019-2025
9.2.4 Japan Ruxolitinib Forecast 2019-2025
9.2.5 Southeast Asia Ruxolitinib Forecast 2019-2025
9.2.6 India Ruxolitinib Forecast 2019-2025
9.3 Ruxolitinib Market Trend (Product Type)
9.4 Ruxolitinib Market Trend (Application)
10 Marketing Channel, Distributors and Customers
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Ruxolitinib Distributors List
10.3 Ruxolitinib Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Ruxolitinib
Table Global Ruxolitinib Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Ruxolitinib Production Market Share by Types in 2018
Figure 5mg Tablets Product Picture
Figure 10mg Tablets Product Picture
Figure 15mg Tablets Product Picture
Figure 20mg Tablets Product Picture
Table Global Ruxolitinib Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Ruxolitinib Consumption Market Share by Applications in 2018
Figure Moderate Myelofibrosis
Figure High Risk Myelofibrosis
Figure Polycythemia Vera
Figure Other
Figure Global Ruxolitinib Revenue (Million USD) (2014-2025)
Figure Global Ruxolitinib Production (K Pcs) (2014-2025)
Figure North America Ruxolitinib Market Size (Million USD) (2014-2025)
Figure Europe Ruxolitinib Market Size (Million USD) (2014-2025)
Figure China Ruxolitinib Market Size (Million USD) (2014-2025)
Figure Japan Ruxolitinib Market Size (Million USD) (2014-2025)
Figure Southeast Asia Ruxolitinib Market Size (Million USD) (2014-2025)
Figure India Ruxolitinib Market Size (Million USD) (2014-2025)
Table Ruxolitinib Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Ruxolitinib in 2018
Figure Manufacturing Process Analysis of Ruxolitinib
Figure Industry Chain Structure of Ruxolitinib
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Ruxolitinib Manufacturing Plants Distribution
Table Ruxolitinib Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Ruxolitinib Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Ruxolitinib Production (K Pcs) of Major Manufacturers (2014-2019)
Table Ruxolitinib Production Market Share of Major Manufacturers (2014-2019)
Figure Ruxolitinib Production Share by Manufacturers in 2018
Table Ruxolitinib Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Ruxolitinib Revenue Market Share of Major Manufacturers (2014-2019)
Figure Ruxolitinib Revenue Share by Manufacturers in 2018
Table Ruxolitinib Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Ruxolitinib Production by Regions 2014-2019 (K Pcs)
Table Global Ruxolitinib Production Market Share by Regions 2014-2019
Figure Global Ruxolitinib Production Market Share by Regions in 2018
Table Global Ruxolitinib Revenue by Regions 2014-2019 (Million USD)
Table Global Ruxolitinib Revenue Market Share by Regions 2014-2019
Figure Global Ruxolitinib Revenue Market Share by Regions in 2018
Table Global Ruxolitinib Consumption by Regions 2014-2019 (K Pcs)
Table Global Ruxolitinib Consumption Market Share by Regions 2014-2019
Figure North America Ruxolitinib Production Growth Rate 2014-2019 (K Pcs)
Figure North America Ruxolitinib Revenue Growth Rate 2014-2019 (Million USD)
Table North America Ruxolitinib Production, Consumption Import and Export (K Pcs)
Figure Europe Ruxolitinib Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Ruxolitinib Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Ruxolitinib Production, Consumption Import and Export (K Pcs)
Figure China Ruxolitinib Production Growth Rate 2014-2019 (K Pcs)
Figure China Ruxolitinib Revenue Growth Rate 2014-2019 (Million USD)
Table China Ruxolitinib Production, Consumption Import and Export (K Pcs)
Figure Japan Ruxolitinib Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Ruxolitinib Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Ruxolitinib Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Ruxolitinib Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Ruxolitinib Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Ruxolitinib Production, Consumption Import and Export (K Pcs)
Figure India Ruxolitinib Production Growth Rate 2014-2019 (K Pcs)
Figure India Ruxolitinib Revenue Growth Rate 2014-2019 (Million USD)
Table India Ruxolitinib Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Ruxolitinib Market Share by Application (2014-2019)
Figure Global Value (Consumption) Ruxolitinib Market Share by Application (2014-2019)
Table Novartis Ruxolitinib Production Sites and Area Served
Table Novartis Ruxolitinib Product Introduction, Application and Specification
Table Novartis Ruxolitinib Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novartis Ruxolitinib Production Growth Rate (2014-2019)
Table Novartis Ruxolitinib Production Market Share (2014-2019)
Figure Novartis Ruxolitinib Revenue Market Share (2014-2019)
Table Novartis Ruxolitinib Main Business and Markets Served
Table Shandong Chuangxin Pharmaceutical Research and Development Ruxolitinib Production Sites and Area Served
Table Shandong Chuangxin Pharmaceutical Research and Development Ruxolitinib Product Introduction, Application and Specification
Table Shandong Chuangxin Pharmaceutical Research and Development Ruxolitinib Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Shandong Chuangxin Pharmaceutical Research and Development Ruxolitinib Production Growth Rate (2014-2019)
Table Shandong Chuangxin Pharmaceutical Research and Development Ruxolitinib Production Market Share (2014-2019)
Figure Shandong Chuangxin Pharmaceutical Research and Development Ruxolitinib Revenue Market Share (2014-2019)
Table Shandong Chuangxin Pharmaceutical Research and Development Ruxolitinib Main Business and Markets Served
Table Orifarm AS Ruxolitinib Production Sites and Area Served
Table Orifarm AS Ruxolitinib Product Introduction, Application and Specification
Table Orifarm AS Ruxolitinib Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Orifarm AS Ruxolitinib Production Growth Rate (2014-2019)
Table Orifarm AS Ruxolitinib Production Market Share (2014-2019)
Figure Orifarm AS Ruxolitinib Revenue Market Share (2014-2019)
Table Orifarm AS Ruxolitinib Main Business and Markets Served
Table Incyte Corporation Ruxolitinib Production Sites and Area Served
Table Incyte Corporation Ruxolitinib Product Introduction, Application and Specification
Table Incyte Corporation Ruxolitinib Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Incyte Corporation Ruxolitinib Production Growth Rate (2014-2019)
Table Incyte Corporation Ruxolitinib Production Market Share (2014-2019)
Figure Incyte Corporation Ruxolitinib Revenue Market Share (2014-2019)
Table Incyte Corporation Ruxolitinib Main Business and Markets Served
Figure Global Ruxolitinib Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Ruxolitinib Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Ruxolitinib Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Ruxolitinib Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Ruxolitinib Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Ruxolitinib Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Ruxolitinib Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Ruxolitinib Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Ruxolitinib Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Ruxolitinib Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Ruxolitinib Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Ruxolitinib Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Ruxolitinib Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Ruxolitinib Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Ruxolitinib Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Ruxolitinib by Type (2019-2025)
Table Global Consumption (K Pcs) of Ruxolitinib by Application (2019-2025)
Table Ruxolitinib Distributors List
Table Ruxolitinib Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
タブレット用ジェスチャー認識の世界市場：市場規模・現状・予測 Gesture recognition is the ability of a device to identify and respond to different gestures, such as movement of hands, fingers, arms, head, or the entire body, of an individual.In gesture recognition technology, a remotely-controlled device can be ideally operated using certain gestures, such as w…- 世界のオフロキサシン錠市場：動向・競争分析 Ofloxacin is a synthetic fluoroquinolone (fluoroquinolones) antibacterial agent useful for the treatment of a number of bacterial infections.In 2018, the global Ofloxacin Tablets market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this stud…
- 世界の口腔内崩壊錠市場：専門的調査 An Orodispersible Tablets is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form…
- 世界の活性炭錠市場：専門的調査 The global Activated Charcoal Tablets market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Activated Charcoal Tablets volume and value at global level, regional level and company level. From a global per…
- 世界のホワイトボックス錠市場：専門的調査 White-box tabet is a new kind of tablet, without a well-known brand name. Regarding to the ststistics from original equipment manufacturer (OEM), white box tablet manufacturers continues to dominate global tablet market, especially Chinese white box devices producers. The global White-Box Tablets ma…